Acute cholestatic hepatitis induced by bupropion prescribed as pharmacological support to stop smoking. A case report

Digestive and Liver Disease

Volumn 33, Issue 8, 2001, Pages 703-706

  Alvaro, D ^a   Onetti Muda, A ^b   Moscatelli, R ^a   Attili, A F ^a  

^a Azienda Sanitaria Locale Azienda Sanitaria Locale Roma H   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bupropion; Intrahepatic cholestasis

Indexed keywords

AMFEBUTAMONE; AMINOTRANSFERASE; ANTIDEPRESSANT AGENT; ANTINUCLEAR ANTIBODY; BILIRUBIN GLUCURONIDE; LIVER ENZYME; METHYLPREDNISOLONE; NEBIVOLOL; QUOMEN;

ADULT; ARTICLE; ASTHENIA; BILE DUCT; BIOCHEMISTRY; CASE REPORT; CHOLESTASIS; CHOLESTATIC HEPATITIS; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; JAUNDICE; LIVER INJURY; LIVER TOXICITY; NAUSEA; SCLERA; SCORING SYSTEM; SMOKING CESSATION; SYMPTOMATOLOGY;

EID: 0035198181     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(01)80049-9     Document Type: Article

References (18)

1. Bupropion SR reduces periodic limb movements associate with arousals from sleep in depressed patients with periodic limb movement disorder
2. Bupropion-SR in treatment of social phobia
3. Bupropion is a nicotinic antagonist
4. Treating anxiety in patients with alcoholism
5. Treatment of nicotine dependence
6. Antidepressants for smoking cessation (Cochrane Review)
7. Preclinical toxicology of bupropion: An overview
8. Overview of clinically significant adverse reactions to bupropion
9. Long-term efficacy and safety of bupropion
10. Acute hepatitis induced by bupropion
11. Biliary epithelium: A new chapter in cell biology
12. Vanishing bile duct syndrome in drug-induced liver disease
13. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis
14. Inflammation-induced cholestasis
15. Ticlopidine-induced cholestatic hepatitis with anti-nuclear antibody in serum
16. The risk of serum aminotransferases in a patient treated with bupropion
17. CYP2B6 mediates the in vitro hydroxylation of bupropion: Potential drug interactions with other antidepressants